Conducted: Ames, human lymphocyte chromosome aberration, rat micronucleus; all negative
“A standard battery of genetic toxicology assays was conducted for vutrisiran (in vitro bacterial mutagenicity, in vitro chromosomal aberration in human peripheral blood lymphocytes, and in vivo rat (bone marrow) micronucleus assay. All assays were adequate and negative.”
✓ VerifiedFDA pharmacology/toxicology review, p. 4Source ↗
Carcinogenicity
Not submitted at approval (PMR); later 2-year mouse and rat studies showed no tumor increase
“Per prior agreement, 2-year carcinogenicity studies of vutrisiran in rat and mouse are to be conducted as post-marketing requirements.”
✓ VerifiedFDA pharmacology/toxicology review, p. 10Source ↗
Reproductive & developmental
Rat fertility (with surrogate), rat and rabbit EFD, rat PPND; rat EFD toxicity at maternally hepatotoxic doses
“The LD was the NOAEL for maternal and developmental toxicity.”
✓ VerifiedFDA pharmacology/toxicology review, p. 9Source ↗
Safety pharmacology
Standalone monkey CV/respiratory telemetry (single dose up to 300 mg/kg); neuro exams in 13-week and 9-month monkey studies
“There were no adverse findings in neurological exams incorporated into the 13-week and 9-month studies in monkey.”
✓ VerifiedFDA pharmacology/toxicology review, p. 62Source ↗